🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

850 results for “Elan” Clear

  1. SKY0402

    Pacira Ireland Limited

    Bunion

    phase 3 small molecule completed

    1 trial

  2. SKY0402

    Pacira Ireland Limited

    Hemorrhoid

    phase 3 small molecule completed

    1 trial

  3. SKY0402

    Pacira Ireland Limited

    Pain

    phase 3 small molecule terminated

    1 trial

  4. SOF/VEL

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 3 small molecule completed

    3 trials

  5. SOF/VEL/VOX

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 3 small molecule completed

    1 trial

  6. Sacituzumab Govitecan-hziy

    Gilead Sciences Ireland UC

    Triple Negative Breast Cancer

    phase 3 small molecule active

    1 trial

  7. Safinamide 100 mg PLACEBO: Safinamide 100 mg PLACEBO film-coated tablets have the same composition as the relevant Investigational Medicinal Products except for the presence of Active Substance that is missing in the placebo formulations. The missing amount of active substance Safinamide methanesulfonate is replaced in the PLACEBO formulation with the same amount of Microcrystalline cellulose, one of the excipients already present in the authorised formulation, Xadago 100 mg film-coated tablets, Xadago 50 m

    Verona Pharma Ireland Limited

    PARKINSON’S DISEASE WITH MOTOR FLUCTUATIONS

    phase 3 small molecule active

    1 trial

  8. Saline, 0.9% sodium chloride solution IV infusion marketed authorized will be used as the placebo and will be supplied by the site. the SmPC previously authorized are Country specific. for Belgium, Spain and Sweden per local requirements under CTDs no SmPCs were submitted., Delandistrogene moxeparvovec-rokl

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    phase 3 small molecule active

    1 trial

  9. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Cerebral Palsy

    phase 3 small molecule completed

    1 trial

  10. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Pain

    phase 3 small molecule completed

    6 trials

  11. Sativex®

    Jazz Pharmaceuticals Ireland Limited

    Spasticity

    phase 3 small molecule completed

    3 trials

  12. Sativex®

    Jazz Pharmaceuticals Ireland Limited

    Detrusor Overactivity

    phase 3 small molecule completed

    1 trial

  13. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Obesity

    phase 3 small molecule active

    1 trial

  14. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Hypothalamic Obesity

    phase 3 small molecule active

    3 trials

  15. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Bardet Biedl Syndrome (BBS)

    phase 3 small molecule completed

    1 trial

  16. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Leptin Receptor Deficiency Obesity

    phase 3 small molecule completed

    1 trial

  17. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Pro-opiomelanocortin (POMC) Deficiency Obesity

    phase 3 small molecule completed

    1 trial

  18. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Bardet-Biedl Syndrome

    phase 3 small molecule completed

    1 trial

  19. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Obesity Associated With Defects in Leptin-melanocortin Pathway

    phase 3 small molecule active

    2 trials

  20. Setmelanotide 2 mg

    Rhythm Pharmaceuticals Netherlands B.V.

    Bardet-Biedl Syndrome

    phase 3 small molecule completed

    1 trial

  21. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    Binge Eating Disorder

    phase 3 small molecule completed

    1 trial

  22. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    Fibromyalgia

    phase 3 small molecule completed

    1 trial

  23. Sodium chloride 0.372% solution, Dexamethasone sodium phosphate for encapsulation into autoerythrocytes

    Quince Therapeutics

    Ataxia Telangiectasia

    phase 3 small molecule active

    1 trial

  24. Sofosbuvir

    Gilead Sciences Ireland UC

    Hepatitis C

    phase 3 small molecule completed

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources